Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.